In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Luminex completes $77mm IPO

Executive Summary

In an IPO netting $77mm, bioassay developer Luminex sold 4.9mm shares (including the exercise of 369k shares of its proposed 675k overallotment) at $17 each, the lower end of its anticipated $17-19 range. It had hoped to raise up to $100mm.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies